Assessment of Genotoxic Potential of <i>Hridayarnava Rasa</i> (A Herbo"‘Mineralo"‘Metallic Ayurvedic Formulation) Using Chromosomal Aberration and Sperm Abnormality Assays
Keywords:Colchicine, cyclophosphamide, genotoxicity, herbo"‘mineral formulations, <i>Tamra bhasma</i>
AbstractObjectives: Herbo"‘mineral formulations are being successfully used in therapeutics since centuries. But recently, they came under the scanner for their metallic contents especially the presence of heavy metals. Hence it is the need of the hour to assess and establish the safety of these formulations through toxicity studies. In line with the various toxicity studies that are being carried out, Government of India expressed the need for conducting genotoxicity studies of different metal"‘ or mineral"‘based drugs. Till date very few Ayurvedic herbo"‘mineral formulations have been studied for their genotoxic potential. The present study is aimed to evaluate the genotoxic potential of Hridayarnava Rasa. Materials and Methods: It was prepared as per classical guidelines and administered to Swiss albino mice for 14 consecutive days. Chromosomal aberration and sperm abnormality assay were done to evaluate the genotoxic potential of the test drugs. Cyclophosphamide (CP) was taken as positive group and results were compared. Results: All treated groups exhibited significant body weight gain in comparison to CP group. Results revealed no structural deformity in the above parameters in comparison to the CP"‘treated group. Conclusion: Reported data showed that both tested samples of Hridayarnava Rasa does not possess genotoxic potential under the experimental conditions and can be safely used.
Chan K. Some aspects of toxic contaminants in herbal medicines. Chemosphere 2003;52:1361"‘71.
Kumar A, Nair AG, Reddy AV, Garg AN. Availability of essential elements in bhasmas: Analysis of Ayurvedic metallic preparations by INAA. J Radio Anal Nucl Chem 2006;270:173"‘80.
Ernst E. Heavy metals in traditional Indian remedies. Eur J Clin Pharmacol 2002;57:891"‘6.
Srinivas A, Surekha PA, Kishore AS, Srinivasan M, Murti PB, Reddy PN. Toxicity profiles of Abharaka and Tamar Bhasmas in different vehicles. J Herbal Med Toxicol 2010;4:189"‘96.
Jagtap CY, Ashok BK, Patgiri BJ, Prajapati PK, Ravishankar B. Acute and sub"‘chronic toxicity study of Tamra Bhasma (Incinerated copper) prepared from Ashodhita (unpurified) and Shodhita (purified) Tamra in rats. Indian J Pharm Sci 2013;75:346"‘52.
Jamadagni PS, Jamadagni SB, Singh R, Gaidhani SN, Upadhyaya S, Hazra J. Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice. Ayu 2013;34:118"‘23.
Prajapati PK, Sarkar PK, Nayak SV, Joshi RD, Ravishankar B. Safety and toxicity profile of some metallic preparations of Ayurveda. Anc Sci Life 2006;25:57"‘63.
Reddy CS, Balekari U, Vemu P, Jinugu VS. Toxicokinetics and tissue distribution studies of mercury in Ayurvedic preparation Shilasindura. Hygeia J D Med 2014;6:81"‘94.
Anonymous, The Gazette of India: Extraordinary, Part II"‘Section 3"‘Sub"‘section (i), Ministry of health and family welfare. New Delhi; 2008. p. 11.
Savalgi PB, Patgiri B, Thakkar JH, Ravishankar B, Gupta VB. Evaluation of subchronic genotoxic potential of Swarna Makshika Bhasma. Ayu 2012;33:418"‘22.
Vardhini NV, Sathya TN, Murthy PB. Assessment of genotoxic potential of herbo"‘mineral preparations"‘ Bhasmas. Curr Sci 2010;99:1096"‘100.
Sathya TN, Balakrishna Murthy P, Vardhini NV. Genotoxicity evaluation of certain bhasmas using micronucleus and comet assays. Internet J Altern Med 2009;7:1.
Krishnagopala B. Rasendrasarasamgraha, Hridroga Chikitsa, ‘Rasavidyotini' hindi commentary by Indradeo Tripathi, Chaukhamba Orientalia, Varanasi; 1998. 2nd ed. p. 380.
Anonymous, The Ayurvedic Formulary Of India, 2nd ed Govt. Of India. Ministry of Health and Family Welfare, Dept. of I. S. M. and H., New Delhi, part 1. 2003. vol. 55. p. 279.
Vagbhattacharya, Rasaratna Samuchchaya, 5/13, Kulkarni D A, Hindi commentary. New Delhi: Meharchand Laxmandas publication; 1998. p. 93.
Vagbhattacharya, Rasaratna Samuchchaya, 5/52, Kulkarni D A, Hindi commentary. New Delhi: Meharchand Laxmandas publication; 1998. p. 101.
Vagbhattacharya, Rasaratna Samuchchaya, 5/52, 53, Kulkarni D A, Hindi commentary. New Delhi: Meharchand Laxmandas publication; 1998. p. 101.
Sharma SN. Rasa Tarangini, 17/40"‘42, Shastri K N, Hindi commentary. Delhi: Motilal Banarasi Das; 2004. p. 418.
Paget GE, Branes JM. Evaluation of Drug activities in pharmacometrics. In: Laurence DR, Bocharach AL, editors. Vol. 1. New York: Academic Press; 1964. p. 135.
Thakkar JH, Solanki HK, Tripathi P, Patel NJ, Jani GK. Evaluation of antimutagenic potential of annona squamosa leaf extract. Elixir Human Phy 2011;31:1960"‘5.
Tijo JH, Whang J. Chromosome preparations of bone marrow cells without prior in vitro culture or in vivo colchicines administration. Stain Technol 1962;37:17"‘20.
Wyrobek AJ, Bruce WR. The induction of sperm cell abnormalities in mice and humans. In: Hallender A, de Serres FJ, editors. Chemical Mutagens. Vol. 5. New York: Plenum Press: 1975. p. 275"‘85.
Ayed"‘Boussema I, Rjiba K, Mnasri N, Moussa A, Bacha H. Genotoxicity valuation of dimethoate to experimental mice by microneucleus, chromosome aberration tests and comet assay. Int J Toxicol 2012;31:78"‘85.
Anonymous. International Commission for protection against environmental mutagenand carcinogens report of committee. Mutat Res 1983;114:120"‘77.
Bajpayee M, Pandey AK, Parmar D, Dhawan A. Current status of short"‘term tests for evaluation of genotoxicity, mutagenicity and carcinogenicity of environmental chemicals and NCEs. Toxicol Mech Methods 2005;15:155"‘80.
Allen E. Cold Spr. Harb. Symp. Quant. Biol. 5:104. In Fraser IEB. The use of colchicine and colcemid for metaphase stasis in the matrix cells of wool follicles. Aust J Biol Sci 1962;16:211"‘7.
Jackson MA, Stack HF, Waters MD. Genetic activity profiles of anticancer drugs. Mutat Res 1996;355:171"‘208.
Anderson D, Bishop JB, Garner RC, Otrosky"‘Wegman P, Selby PB. Cyclophosphmide: Review of its mutagenicity for an assesssment of potential germ cell risks. Mutat Res 1995;330:115"‘81.
Krisna G, Petrer J, Anderson J, Theiss J. Use of cyclophosphamide as a positive control in dominant lethal and mammalian assays. Mutat Res 1995;335:331"‘7.
Wyrobek AJ, Gordon LA, Burkhart JG, Francis MW, Kapp RW Jr, Letz G, et al. An evaluation of the mouse sperm morphology test and other sperm tests in nonhuman mammals: A report of the U. S. Environmental Protection Agency Gene Toxicology Program. Mutat Res 1983;115:1"‘72.
Odeigah PG. Sperm head abnormalities and dominant lethal effects of formaldehyde in albino rats. Mutat Res 1997;389:141"‘8.
Krzanowska H. Sperm head abnormalities in relation to the age and strains of mice. J Reprod Fertil 1981;62:385"‘92.
Bruce WR, Heddle JA. The mutagenic activity of 61 agents as determined by the micronucleus, Salmonella and sperm abnormality assays. Can J Genet Cytol 1979;21:319"‘34.